Association of HDL cholesterol and triglycerides with mortality in patients with heart failure

H F G Freitas1, E A Barbosa, F H F P Rosa

  • 1Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil. dclfreitas@incor.usp.br

Insights

Higher serum HDL cholesterol and triglycerides correlate with better survival rates in heart failure patients. This study investigated lipid profiles and prognosis in 833 outpatients, finding these fats beneficial for heart health outcomes.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Serum lipoproteins are linked to survival in various heart failure types.
  • Prognosis in heart failure patients, including those with Chagas' heart disease, requires further investigation regarding lipid profiles.

Purpose of the Study:

  • To test the association between serum lipoprotein levels and prognosis in a cohort of outpatients with heart failure.
  • To examine the impact of lipid profiles on survival rates in patients with diverse heart failure etiologies.

Main Methods:

  • A cohort of 833 outpatients with New York Heart Association functional classes III and IV heart failure was studied.
  • Survival rates were analyzed using Kaplan-Meier method and Cox proportional hazards models.
  • Lipid profiles were assessed in relation to mortality, considering factors like age, gender, and heart failure etiology.

Main Results:

  • Higher serum triglycerides (HR=0.97) and HDL cholesterol (HR=0.99) were significantly associated with lower mortality.
  • Age, male gender, and idiopathic dilated cardiomyopathy were independently associated with increased mortality.
  • The study included diverse etiologies: ischemic cardiomyopathy (21%), Chagas' heart disease (17%), hypertensive cardiomyopathy (16%), and idiopathic dilated cardiomyopathy (36%).

Conclusions:

  • Elevated serum HDL cholesterol and triglycerides are associated with improved survival in outpatients with heart failure.
  • Lipid profiles, particularly HDL cholesterol and triglycerides, represent potential prognostic markers in heart failure management.
  • Understanding these associations can inform therapeutic strategies for heart failure patients.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...